Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 42, Issue 7, 2001, Pages 1617-1625

  Hangai, M ^a   Murata, T ^a   Miyawaki, N ^a   Spee, C ^a   Lim, J I ^a   He, S ^a   Hinton, D R ^a   Ryan, S J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; VASCULOTROPIN; VISUAL PIGMENT;

ARTICLE; CHOROID CAPILLARY LAYER; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RNA ANALYSIS; STIMULUS RESPONSE; STROMA CELL; SUBRETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIUM;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; CHOROIDAL NEOVASCULARIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; HUMANS; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; MIDDLE AGED; PIGMENT EPITHELIUM OF EYE; PROTEINS; RNA, MESSENGER; TIME FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035009998     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Argon laser photocoagulation for neovascular maculopathy: Five-year results from randomized clinical trials
2. Angiogenesis inhibition in age-related macular degeneration
3. Mechanisms of retinal and choroidal neovascularization
4. The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration
5. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes
6. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor
7. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes
8. Expression of vascular endothelial growth factor in experimental choroidal neovascularization
9. Increased expression of angiogenic growth factors in age-related maculopathy
10. Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes
11. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris: Evidence for a trophic paracrine relation
12. Pigment epithelium-derived factor: Neurotrophic activity and identification as a member of the serine protease inhibitor gene family
13. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
14. Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells
15. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina
16. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
17. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
18. Vascular endothelial growth factor/vascular permeability factor is temporally anti spatially correlated with ocular angiogenesis in a primate model
19. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
20. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
21. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy
22. Vascular endothelial growth factor: 20th-century mechanisms, 21st-century therapies
23. Ocular neovascularization: Clarifying complex interactions
24. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization
25. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization
26. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
27. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
28. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
29. Signaling vascular morphogenesis and maintenance
30. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
31. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
32. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
33. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells
34. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro
35. Selective killing of RPE with a vascular endothelial growth factor chimeric toxin
36. Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization
37. Advanced glycation end products increase retinal vascular endothelial growth factor expression
38. Regulation of vascular endothelial growth factor expression by insulin-like growth factor I
39. Transforming growth factor-β regulates human retinal pigment epithelial cell phagocytosis by influencing a protein kinase C-dependent pathway
40. Stability of globin mRNA in terminally differentiating murine erythroleukemia cells
41. Regulation of messenger RNA stability in mouse erythroleukemia cells
42. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
43. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues
44. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
45. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
46. SV40-immortalized and primary cultured human retinal pigment epithelial cells share similar patterns of cytokine-receptor expression and cytokine responsiveness
47. Selective killing of RPE with a vascular endothelial growth factor chimeric toxin
48. Senescence of the retinal pigment epithelium
49. The role of retinal pigment epithelium in the involution of subretinal neovascularization
50. Morphologic observations on experimental subretinal neovascularization in the monkey
51. Angiopoietin-1 protects the adult vasculature against plasma leakage
52. Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells
53. Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration
54. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
55. Angiopoietin-1 is an apoptosis survival factor for endothelial cells